GHK-Cu — Copper Peptide (Skin / Wound Healing Research)

GHK-Cu (glycyl-L-histidyl-L-lysine–copper) is a naturally occurring copper-binding tripeptide studied for roles in wound healing, extracellular matrix remodeling, and skin biology. It is used in research and cosmetic contexts primarily as a topical, but is also discussed as an injectable in underground circles.

Research Use Disclaimer: This content is for educational research discussion only and is not medical advice. Do not self-treat medical conditions. Product purity and sterility are critical variables; cosmetic/topical products are not sterile injectables.

Description

GHK is a human plasma peptide that can chelate copper (Cu2+). The copper complex (GHK-Cu) has been studied for effects on collagen and elastin biology, fibroblast activity, and gene expression patterns related to tissue remodeling. Much of the evidence base is preclinical or dermatologic/cosmetic research rather than large modern randomized trials.

Potential Research Benefits

  • Wound healing support signals in skin models.
  • Collagen / ECM remodeling: modulation of fibroblast activity and matrix proteins (preclinical).
  • Skin appearance: used in topical products for texture/fine lines (cosmetic claims vary).
  • Anti-inflammatory / antioxidant signaling in certain experimental systems.
  • Hair biology: explored in hair follicle and scalp-skin contexts.

Mechanism of Action (Research Discussion)

Proposed mechanisms include copper delivery to copper-dependent enzymes, altered signaling in fibroblasts/keratinocytes, and broad gene expression modulation in pathways related to inflammation, remodeling, and repair. Reported effects are highly context-dependent (dose, formulation, tissue, and model system).

Side Effects

  • Topical: irritation, redness, dermatitis (especially with higher concentrations or sensitive skin).
  • Injectable discussions: injection site pain/irritation; unknown systemic risks due to limited controlled human data.
  • Allergic reactions are possible to any topical formulation component.

Contraindications (Precautionary)

  • Known copper metabolism disorders (theoretical concern; consult clinician).
  • Pregnancy/breastfeeding (limited safety data for concentrated cosmetic actives).
  • Active dermatitis/compromised barrier: patch test and consider lower concentrations.

SubQ vs IM (If Injectable)

There is no robust clinical literature establishing SubQ vs IM advantages for GHK-Cu. If discussed as an injectable in research settings, SubQ is typically chosen due to lower discomfort and smaller volumes. Do not inject topical products; sterility and excipients are not appropriate for parenteral use.

Reconstitution and Dosing (Common Informal Patterns)

Injectable vial example (10 mg)

Add 5.0 mL bac water → concentration = 2 mg/mL.

  • 0.50 mL (50 IU) = 1.0 mg
  • 1.00 mL (100 IU) = 2.0 mg

Injectable vial example (50 mg)

Add 10.0 mL bac water → concentration = 5 mg/mL.

  • 0.20 mL (20 IU) = 1.0 mg
  • 0.40 mL (40 IU) = 2.0 mg

Common non-clinical injection pattern discussed online: 1–2 mg daily (often for 4–8 weeks). Not clinically validated.

Topical Use (Common Cosmetic Ranges)

Topical GHK-Cu products vary widely (often in the 0.01%–0.1% range, sometimes higher). Start low, patch test, and avoid combining multiple strong actives until tolerance is established.

Stacking Suggestions

  • Topical retinoids: commonly paired in skincare routines, but introduce slowly to minimize irritation.
  • Vitamin C and sunscreen: supportive of collagen/photoprotection context.
  • Microneedling: sometimes combined with copper peptides in cosmetic protocols; infection control matters.

Research Sources (PubMed)

  1. Discovery/characterization of GHK and copper binding in plasma. Proc Natl Acad Sci U S A. 1973. PMID: 4519650
  2. GHK-Cu and wound healing / tissue remodeling signals (review/experimental). FASEB J. 1998. PMID: 9737716
  3. Copper peptides and skin repair biology overview. Clin Dermatol. 2008. PMID: 19095113
  4. GHK-Cu influences gene expression relevant to tissue remodeling (systems biology style analysis). Biomed Res Int. 2014. PMID: 24783244
  5. GHK-Cu and collagen/elastin related pathways in fibroblasts (experimental). J Invest Dermatol. 1999. PMID: 10233764
  6. Copper and wound repair / angiogenesis context relevant to copper peptides. Wound Repair Regen. 2003. PMID: 12753574
Scroll to Top